Development of a Pentavalent Broadly Protective Nucleoside-Modified mRNA Vaccine against Influenza B Viruses

Investigators focused on the development of a universal influenza B virus vaccine based on the lipid nanoparticle-encapsulated nucleoside-modified mRNA platform.